Literature DB >> 27432932

Targeted Therapies in Older Adults With Breast Cancer: What Do We Know?

Shlomit Strulov Shachar1, Arti Hurria2, Hyman B Muss3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27432932     DOI： 10.1200/JCO.2016.68.8242

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  Comparison of outcomes in a population-based cohort of metastatic breast cancer patients receiving anti-HER2 therapy with clinical trial outcomes.

Authors:  Inna Y Gong; Andrew T Yan; Craig C Earle; Maureen E Trudeau; Andrea Eisen; Kelvin K W Chan
Journal:  Breast Cancer Res Treat       Date:  2020-03-31       Impact factor: 4.872

2.  Real-world treatment in patients with HER2+ metastatic breast cancer : Treatment decisions in HER2+ mBC.

Authors:  R Colomer; P Hall; M Szkultecka-Debek; R C Bondi; A Flinois; S Auziere; J Y Le Cléac'h
Journal:  Breast Cancer Res Treat       Date:  2017-11-23       Impact factor: 4.872

3.  Management of triple negative breast cancer in a centenarian.

Authors:  Andrew Donaldson; Lilia Lunt; Andrea Madrigrano
Journal:  Cancer Rep (Hoboken)       Date:  2022-06-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.